血清miR-124、miR-132、miR-134对卒中后认知障碍的预测作用
Prediction of Post-Stroke Cognitive Impairment by Serum miR-124, miR-132, miR-134
DOI: 10.12677/ACM.2022.12101309, PDF,   
作者: 李 丽:青岛大学第十一临床学院神经内科,山东 青岛;苏 琪, 解忠祥, 车峰远*:临沂市人民医院神经内科,山东 临沂;刘婉琪:锦州医科大学,辽宁 锦州
关键词: 卒中后认知障碍miR-124miR-132miR-134急性缺血性脑卒中神经缺损ROCPost-Stroke Cognitive Impairment miR-124 miR-132 miR-134 Acute Ischemic Stroke Neurologi-cal Deficit ROC
摘要: 背景:卒中后痴呆是脑卒中后最常见的心理行为障碍并发症,其增加了死亡率,极大降低了卒中患者的生活质量。目前的研究认为,血清微小RNA、氧化应激因子、血清代谢物等生物学标志物等危险因素均可作为PSCI的预警因子,但尚无统一定论。因此亟须寻找新的诊断标志物和诊断方法以提升PSCI患者等的早期检出率。目的:探讨miR-124、miR-132、miR-134对卒中后认知障碍(post-stroke cognitive impairment, PSCI)的预测效能。方法:选取2021年5月至2022年10月本院收治的67例脑梗死患者,根据6个月内是否发生卒中后认知障碍分为PSCI组(n = 33)、卒中后认知正常(post-stroke cognitive normality, PSCN)组(n = 34),同时收集36例健康对照组的样本。采用实时定量聚合酶链式反应(qRT-PCR)方法检测miR-124、miR-132与miR-134的表达。ANOVA检验比较三组基线资料和miR-124、miR-132、miR-134与简易智力状态检查量表(MMSE)评分,采用Pearson及偏相关性分析miR-124、miR-132、miR-134与MMSE评分相关性,受试者工作特征曲线(ROC)分析miR-124、miR-132、miR-134预测PSCN的价值。结果:miR-124、miR-132、miR-134均在PSCI组的表达最高,其次是PSCN组和健康对照组;PSCI组的MMSE评分最低,其次是PSCN组和AMC组,差异有统计学意义(P < 0.05);miR-124、miR-132、miR-134与MMSE评分呈负相关(P < 0.05);miR-124、miR-132、miR-134预测PSCI的AUC为0.902,大于单一指标预测(P < 0.05)。结论:miR-124、miR-132、miR-134可作为临床评估脑梗死后PSCI发生风险的非侵入性指标,有助于临床早期识别、干预,以改善患者预后。
Abstract: Background: Post-stroke dementia is the most common complication of psychological and behav-ioral disorders after stroke, which increases mortality and greatly reduces the quality of life of stroke patients. According to the current research, serum micro-RNA, oxidative stress factors, se-rum metabolites and other risk factors can be used as early warning factors of PSCI, but there is no unified conclusion. Therefore, there is an urgent need to find new diagnostic markers and diagnos-tic methods to improve the early detection rate of PSCI patients. Objective: To explore the predic-tive efficacy of miR-124, miR-132 and miR-134 in post-stroke cognitive impairment (PSCI). Methods: Sixty-seven patients with cerebral infarction treated in our hospital from May 2021 to October 2022 were divided into PSCI group (n = 33) and post-stroke cognitive normality group (n = 34) according to the occurrence of post-stroke cognitive impairment within 6 months. At the same time, 36 healthy controls were collected. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-124, miR-132 and miR-134. The baseline data of the three groups and the scores of miR-124, miR-132, miR-134 and mini-mental state examination (MMSE) were compared by ANOVA test. Pearson and partial correlation were used to analyze the correlation between miR-124, miR-132, miR-134 and MMSE scores. The value of miR-124, miR-132 and miR-134 in predicting PSCN was analyzed by receiver working characteristic curve (ROC). Results: The scores of miR-124, miR-132 and miR-134 were the highest in PSCI group, followed by PSCN group and healthy control group, the MMSE score of PSCI group was the lowest, followed by PSCN group and AMC group, the difference was statistically significant (P < 0.05), miR-124, miR-132, miR-134 were negatively correlated with MMSE score (P < 0.05), and the AUC of PSCI predicted by miR-124, miR-132 and miR-134 was 0.902, which was higher than that predicted by single index (P < 0.05). Conclusion: miR-124, miR-132 and miR-134 can be used as non-invasive indexes to evalu-ate the risk of PSCI after cerebral infarction, which is helpful for early clinical identification and in-tervention to improve the prognosis of patients.
文章引用:李丽, 苏琪, 解忠祥, 刘婉琪, 车峰远. 血清miR-124、miR-132、miR-134对卒中后认知障碍的预测作用[J]. 临床医学进展, 2022, 12(10): 9050-9058. https://doi.org/10.12677/ACM.2022.12101309

参考文献

[1] 《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志, 2022, 19(2): 136-144.
[2] 张钱林, 鲁平, 张杰文. 血清脂蛋白相关磷酸酶A2与缺血性脑卒中致血管性痴呆的相关性[J]. 中华医学杂志, 2018, 98(15): 1171-1175.
[3] 张帅康. 《卒中后认知障碍管理专家共识2021》发布[N]. 人民政协报, 2021-07-21(005).
[4] Qu, Y., Zhuo, L., Li, N., et al. (2015) Prevalence of Post-Stroke Cognitive Impairment in China: A Community-Based, Cross-Sectional Study. PLOS ONE, 10, e0122864. [Google Scholar] [CrossRef] [PubMed]
[5] 张雪玲, 王黎明, 陈念东, 等. mir-132调控神经环路-突触可塑性与改善卒中后痴呆的机制研究[J]. 中风与神经疾病杂志, 2017, 34(12): 1080-1083.
[6] Andrade, G.M., Bomfim, M.M., Del Collado, M., et al. (2019) Oxygen Tension Modulates Extracellular Vesicles and Its miRNA Con-tents in Bovine Embryo Culture Medium. Molecular Reproduction and Development, 86, 1067-1080. [Google Scholar] [CrossRef] [PubMed]
[7] Xiao, Y. and Macrae, I.J. (2019) Toward a Comprehensive View of Mi-croRNA Biology. Molecular Cell, 75, 666-668. [Google Scholar] [CrossRef] [PubMed]
[8] 杨帆, 李兴义, 满劲进, 等. 卒中后认知障碍早期预测因素的研究进展[J]. 神经损伤与功能重建, 2022, 17(4): 218-21.
[9] Zhu, Y., Zhao, S., Fan, Z., et al. (2020) Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-Stroke Cognitive Im-pairment during the Acute Phase in Chinese Minor Stroke Patients. Frontiers in Aging Neuroscience, 12, Article No. 236. [Google Scholar] [CrossRef] [PubMed]
[10] Huang, S., Zhao, J., Huang, D., et al. (2016) Serum Mir-132 Is a Risk Marker of Post-Stroke Cognitive Impairment. Neuroscience Letters, 615, 102-106. [Google Scholar] [CrossRef] [PubMed]
[11] 王雪清, 李文新. miRNA在乳腺癌中的研究进展[J]. 疾病监测与控制, 2019, 13(4): 301-304+316.
[12] Liu, D.Z., Tian, Y., Ander, B.P., et al. (2010) Brain and Blood MicroRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate Seizures. Journal of Cerebral Blood Flow & Metabolism, 30, 92-101. [Google Scholar] [CrossRef] [PubMed]
[13] 凌加平, 郭芳. 1.5 t Mri联合血浆mir-124对急性脑卒中患者的临床诊断价值[J]. 中国CT和MRI杂志, 2022, 20(2): 11-13.
[14] Periyasamy, P., Liao, K., Kook, Y.H., et al. (2018) Cocaine-Mediated Downregulation of Mir-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling. Molecular Neurobiology, 55, 3196-3210. [Google Scholar] [CrossRef] [PubMed]
[15] 王小林, 邵宏敏. mir-124在血管性痴呆患者血清中表达差异及其意义[J]. 国际神经病学神经外科学杂志, 2020, 47(5): 489-493.
[16] 谢民, 李社芳, 邢海燕, 等. mir-124靶向调控Stat3调节动脉粥样硬化中血管内皮细胞的生物学特性[J]. 中国老年学杂志, 2019, 39(1): 161-165.
[17] 张敬炟, 戴舒惠. MicroRNA-124通过调控Pten促进脑缺血损伤小鼠神经轴突生长和运动功能恢复[J]. 陆军军医大学学报, 2022, 44(14): 1478-1485.
[18] Xie, B., Zhou, H., Zhang, R., et al. (2015) Serum mir-206 and mir-132 as Poten-tial Circulating Biomarkers for Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 45, 721-731. [Google Scholar] [CrossRef
[19] Cogswell, J.P., Ward, J., Taylor, I.A., et al. (2008) Identification of miRNA Changes in Alzheimer’s Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways. Journal of Alzheimer’s Disease, 14, 27-41. [Google Scholar] [CrossRef
[20] 冯婷婷, 马英. 缺血性脑卒中后炎症反应中microRNA的神经保护作用及其机制研究进展[J]. 中国临床神经科学, 2021, 29(6): 696-700.
[21] Liu, W., Wu, J., Huang, J., et al. (2017) Electroacupuncture Regulates Hippocampal Synaptic Plasticity via mir-134- Mediated Limk1 Function in Rats with Ischemic Stroke. Neural Plasticity, 2017, Article ID: 9545646. [Google Scholar] [CrossRef] [PubMed]
[22] Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297. [Google Scholar] [CrossRef
[23] Gao, J., Wang, W.Y., Mao, Y.W., et al. (2010) A Novel Pathway Regulates Memory and Plasticity via Sirt1 and miR-134. Nature, 466, 1105-1109. [Google Scholar] [CrossRef] [PubMed]